Cempra

Cempra is committed to discovering and developing highly differentiated drugs that can cure bacterial infections and improve the quality of life for patients with chronic diseases. The company balances near-term product development opportunities, including the macrolide CEM-101, while investing in future new technology products to obtain the next generation of antibiotics.